Obstetric Comorbidity Index in Postpartum Hemorrhage

Launched by MAHIDOL UNIVERSITY · May 24, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how well the Obstetric Comorbidity Index can predict serious health issues in women who experience heavy bleeding after a cesarean section. The researchers want to see if this index can help identify those at higher risk for severe complications from postpartum hemorrhage, which is when a mother loses a significant amount of blood after giving birth.

To be eligible for this study, participants must be women who have had a cesarean delivery and have been diagnosed with postpartum hemorrhage. However, women who had a cesarean before 24 weeks of pregnancy, those whose medical records are missing important information, or those who lost less than 1,000 ml of blood in the first 24 hours after delivery will not be included. If you join this trial, you can expect to help researchers learn more about postpartum hemorrhage and improve care for future patients, all while being closely monitored for your health and safety during the study.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • The patients underwent cesarean delivery with the diagnosis of postpartum hemorrhage (ICD-10 coding O72.1)
• Exclusion Criteria:
• • Cesarean delivery at less than 24 weeks of gestation
• • A patient chart that does not contain primary outcome data eg. absence of anesthetic record
• • Blood loss less than 1,000 ml in the first 24 hours postpartum

Trial Officials